MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Effects of education level on motor and non-motor symptoms of Brazilian patients with Parkinson’s disease.

    E. Lirani-Silva, R. Vitório, P.C. Santos, C. Teixeira-Arroyo, L. Simieli, N. Conceicao, P. Sousa, L. Gobbi (Rio Claro, Brazil)

    Objective: To investigate the influence of education level (EL) on motor and non-motor aspects of Parkinson’s disease (PD) in a Brazilian sample. Background: Only 30%…
  • 2017 International Congress

    Information Content of Spoken Language in Parkinson’s Disease Without Dementia

    A. Roberts, D. Post, S. Gutierrez (Evanston, IL, USA)

    Objective: Investigate differences in spoken language content in Parkinson’s disease (PD) compared to older controls. Background: Conveying information is a primary goal of communication. PD language…
  • 2017 International Congress

    Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes

    P. Schmidt, F. Cubillos, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

    Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • 2017 International Congress

    TMEM230 mutation analysis in Parkinson’s disease in a Chinese population

    Z. Liu (Changsha, China)

    Objective: To investigate the prevalence of TMEM230 mutations in Chinese patients with familial and sporadic PD. Background: Recently, Hanxiang Deng and colleagues identified a missense…
  • 2017 International Congress

    Higher genetic load is associated with an earlier disease onset but not with more rapid disease progression in Parkinson’s disease

    S. Lerche, I. Wurster, B. Roeben, E. Schaeffer, C. Schulte, S. Akbas, A.-K. Hauser, C. Deuschle, T. Gasser, D. Berg, K. Brockmann (Tuebingen, Germany)

    Objective: To evaluate the influence of genetic variants on phenotypic variability and disease progression in PD patients. Background: Parkinson’s disease (PD) patients show a large…
  • 2017 International Congress

    Understanding the role of LRRK2 in Indian population

    A. Kishore, M. Sturm, A. Sreelatha, S. Robert, S. Krishnan, M. Banerjee, O. Riess, P. Bauer, R. Kruger, T. Gasser, M. Sharma (Trivandrum, India)

    Objective: Genomic approaches  in Caucasian population show little transferability to other ethnically diverse populations such as Indian population. Understanding the genetic architecture of a disease…
  • 2017 International Congress

    Assessing the response to L-dopa/carbidopa intestinal gel infusion (Deudopa) based on genetic status.

    A. Thaler, A. Hillel, H. Shabtai, N. Giladi, T. Gurevich (Tel-Aviv, Israel)

    Objective: To asses genetic impact on dosage of L-dopa/carbidopa treatment Background: L-dopa/carbidopa intestinal gel infusion (LCIG) is a method of continuous dopaminergic stimulation used in…
  • 2017 International Congress

    Genotype-phenotype correlations in Parkinson disease patients who carry mutations in the GBA gene.

    A. Thaler, T. Gurevich, A. Ezra, M. Kestenbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To assess genotype-phenotype relationship between mild and severe GBA mutation carriers among patients with Parkinson's disease  Background: Mutations in the Glucocerebrocidase gene (GBA) are…
  • 2017 International Congress

    Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease

    S. Gunzler, S. Mittal, C. Tatsuoka, A. Wilson-Delfosse, S. Chen, J. Mieyal, I.J. Feng, D. Riley (Cleveland, OH, USA)

    Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…
  • « Previous Page
  • 1
  • …
  • 1678
  • 1679
  • 1680
  • 1681
  • 1682
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley